Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05082181 · ClinicalTrials.gov registry record · NA

Telephone-Based Support Programs for People With Epilepsy

A NA study of Epilepsy, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT05082181 is a NA study of Epilepsy that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 120 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05082181, a NA study of Epilepsy, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This is a two-arm randomized controlled trial to compare telephone-based depression self-management (UPLIFT) to telephone-based support groups (BOOST). A sample of 120 English- and Spanish-speaking people with epilepsy (PWE) with elevated depressive symptoms will be enrolled. Both interventions are 8-week programs delivered in one-hour weekly sessions to groups of about 6 participants. Changes in depressive symptoms, quality of life and seizures will be assessed over 12 months. The trial will also examine mediators and moderators of treatment effects.

Conditions Studied

Interventions

  • BEHAVIORAL UPLIFT (Using Practice and Learning to Increase Favorable Thoughts)
  • BEHAVIORAL BOOST (Bringing Out Our Strength Together)

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2021-11-09
Est. Completion 2027-08-31
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05082181

The ClinicalTrials.gov registry entry for NCT05082181 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (87% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is the first listed.

NCT05082181 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05082181 about?

NCT05082181 is a clinical study titled "Telephone-Based Support Programs for People With Epilepsy". This is a two-arm randomized controlled trial to compare telephone-based depression self-management (UPLIFT) to telephone-based support groups (BOOST). A sample of 120 English- and Spanish-speaking people with epilepsy (PWE) with elevated depressive symptoms will be enrolled. Both interventions are ...

What is the current status of trial NCT05082181?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2021-11-09. Estimated completion is 2027-08-31.

What conditions does trial NCT05082181 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT05082181?

The interventions under investigation include: UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) (BEHAVIORAL), BOOST (Bringing Out Our Strength Together) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05082181?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05082181 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.